N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride

C72H105ClF4N14O12 — CID 159136925

IUPACN-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride
SMILESCC(C)c1nnc(C2CCC(C(=O)CCCNC(=O)c3cn(-c4ccccc4F)nc3C(F)(F)F)CC2)o1.CC(C)c1nnc(C2CCC(C(=O)NCCCC(=O)OC(C)(C)C)CC2)o1.CC(C)c1nnc(C2CCC(C(=O)NCCN)CC2)o1.CC(C)c1nnc(C2CCC(C(=O)O)CC2)o1.Cl
InChIInChI=1S/C26H29F4N5O3.C20H33N3O4.C14H24N4O2.C12H18N2O3.ClH/c1-15(2)24-32-33-25(38-24)17-11-9-16(10-12-17)21(36)8-5-13-31-23(37)18-14-35(34-22(18)26(28,29)30)20-7-4-3-6-19(20)27;1-13(2)18-22-23-19(26-18)15-10-8-14(9-11-15)17(25)21-12-6-7-16(24)27-20(3,4)5;1-9(2)13-17-18-14(20-13)11-5-3-10(4-6-11)12(19)16-8-7-15;1-7(2)10-13-14-11(17-10)8-3-5-9(6-4-8)12(15)16;/h3-4,6-7,14-17H,5,8-13H2,1-2H3,(H,31,37);13-15H,6-12H2,1-5H3,(H,21,25);9-11H,3-8,15H2,1-2H3,(H,16,19);7-9H,3-6H2,1-2H3,(H,15,16);1H
InChIKeyBYWGRVOUGCAUOF-UHFFFAOYSA-N
MW1470.16 g/mol
LogP13.81
Rot. Bonds24

About N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride

N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride (PubChem CID 159136925) has the molecular formula C72H105ClF4N14O12 and a molecular weight of 1470.16 g/mol. Its IUPAC name is N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride.

Molecular Properties

Compound NameN-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride
PubChem CID159136925
Molecular FormulaC72H105ClF4N14O12
Molecular Weight1470.16 g/mol
Exact Mass1468.77
IUPAC NameN-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride
SMILESCC(C)c1nnc(C2CCC(C(=O)CCCNC(=O)c3cn(-c4ccccc4F)nc3C(F)(F)F)CC2)o1.CC(C)c1nnc(C2CCC(C(=O)NCCCC(=O)OC(C)(C)C)CC2)o1.CC(C)c1nnc(C2CCC(C(=O)NCCN)CC2)o1.CC(C)c1nnc(C2CCC(C(=O)O)CC2)o1.Cl
InChIInChI=1S/C26H29F4N5O3.C20H33N3O4.C14H24N4O2.C12H18N2O3.ClH/c1-15(2)24-32-33-25(38-24)17-11-9-16(10-12-17)21(36)8-5-13-31-23(37)18-14-35(34-22(18)26(28,29)30)20-7-4-3-6-19(20)27;1-13(2)18-22-23-19(26-18)15-10-8-14(9-11-15)17(25)21-12-6-7-16(24)27-20(3,4)5;1-9(2)13-17-18-14(20-13)11-5-3-10(4-6-11)12(19)16-8-7-15;1-7(2)10-13-14-11(17-10)8-3-5-9(6-4-8)12(15)16;/h3-4,6-7,14-17H,5,8-13H2,1-2H3,(H,31,37);13-15H,6-12H2,1-5H3,(H,21,25);9-11H,3-8,15H2,1-2H3,(H,16,19);7-9H,3-6H2,1-2H3,(H,15,16);1H
InChIKeyBYWGRVOUGCAUOF-UHFFFAOYSA-N
XLogP13.81
TPSA367.49 Ų
H-Bond Donors5
H-Bond Acceptors22
Rotatable Bonds24
Heavy Atoms103
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001470.16
LogP ≤ 513.81
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride?
The IUPAC name of N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride (CID 159136925) is N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride.
What is the SMILES notation for N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride?
The canonical SMILES for N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride is CC(C)c1nnc(C2CCC(C(=O)CCCNC(=O)c3cn(-c4ccccc4F)nc3C(F)(F)F)CC2)o1.CC(C)c1nnc(C2CCC(C(=O)NCCCC(=O)OC(C)(C)C)CC2)o1.CC(C)c1nnc(C2CCC(C(=O)NCCN)CC2)o1.CC(C)c1nnc(C2CCC(C(=O)O)CC2)o1.Cl.
What is the InChIKey of N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride?
The InChIKey is BYWGRVOUGCAUOF-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H29F4N5O3.C20H33N3O4.C14H24N4O2.C12H18N2O3.ClH/c1-15(2)24-32-33-25(38-24)17-11-9-16(10-12-17)21(36)8-5-13-31-23(37)18-14-35(34-22(18)26(28,29)30)20-7-4-3-6-19(20)27;1-13(2)18-22-23-19(26-18)15-10-8-14(9-11-15)17(25)21-12-6-7-16(24)27-20(3,4)5;1-9(2)13-17-18-14(20-13)11-5-3-10(4-6-11)12(19)16-8-7-15;1-7(2)10-13-14-11(17-10)8-3-5-9(6-4-8)12(15)16;/h3-4,6-7,14-17H,5,8-13H2,1-2H3,(H,31,37);13-15H,6-12H2,1-5H3,(H,21,25);9-11H,3-8,15H2,1-2H3,(H,16,19);7-9H,3-6H2,1-2H3,(H,15,16);1H.
What are the key properties of N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride?
N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride has a molecular weight of 1470.16 g/mol, XLogP of 13.81, 24 rotatable bonds, 5 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-aminoethyl)-4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxamide;tert-butyl 4-[[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexanecarbonyl]amino]butanoate;1-(2-fluorophenyl)-N-[4-oxo-4-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexyl]butyl]-3-(trifluoromethyl)pyrazole-4-carboxamide;4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)cyclohexane-1-carboxylic acid;hydrochloride is sourced from PubChem (CID 159136925), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).